Laman Utama500257 • BOM
add
Lupin Ltd
Tutup sebelumnya
₹1,955.60
Julat hari
₹1,957.15 - ₹1,995.70
Julat tahun
₹1,645.00 - ₹2,403.45
Permodalan pasaran
902.50B INR
Bilangan Purata
32.26K
Nisbah P/E
27.57
Hasil dividen
-
Pertukaran utama
NSE
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (INR) | Mac 2025info | Perubahan T/T |
|---|---|---|
Hasil | 56.67B | 14.24% |
Perbelanjaan pengendalian | 29.68B | 34.53% |
Pendapatan bersih | 7.73B | 114.93% |
Margin untung bersih | 13.63 | 88.00% |
Pendapatan bagi setiap syer | 16.87 | 114.63% |
EBITDA | 13.05B | 41.04% |
Kadar cukai berkesan | 12.67% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (INR) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 42.01B | 106.51% |
Jumlah aset | 292.05B | 21.70% |
Jumlah liabiliti | 119.11B | 23.76% |
Jumlah ekuiti | 172.94B | — |
Syer tertunggak | 456.30J | — |
Harga kepada buku | 5.19 | — |
Pulangan pada aset | — | — |
Pulangan pada modal | 12.08% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (INR) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 7.73B | 114.93% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is primarily a manufacturer of generic drugs, covering therapeutic areas such as paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis. Wikipedia
Diasaskan
1968
Ibu pejabat
Tapak web
Pekerja
19,210
